Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session

Proven Innovation Models in Life Sciences Through Industry-University Collaboration

Fri, Jun 11, 2021 · 12:00 PM · EDT
About This Webinar

Join us for a panel discussion with leaders from higher education and industry to listen and learn about how these two groups can unite to identify and operationalize innovations that create industry advancements.
Our esteemed panel will review how collaborative efforts have driven recent innovation in life sciences that are both cost effective and timely.

This is a live session with an opportunity for questions and answers at the end.

Who can view: Everyone
Webinar Price: Free
Featured Presenters
Webinar hosting presenter
Senior Vice President & General Manager
Dr. Hartounian earned his Ph.D. in Chemical Engineering from the University of Delaware. He leads the Biopharma Division at NJII, working with colleagues in industry and academia to help biopharmaceutical companies transform discovery into commercial production. He has 30 years of experience in the biotechnology industry working for companies such as DuPont, Monsanto, SkyePharma and Vyteris. He also founded the companies MicroIslet, Protagenic Therapeutics, and DiaVacs and has worked in a variety of product lines — including cell therapy, oncology, women’s health, pain management and drug delivery. In addition, Dr. Hartounian is an adjunct associate professor of Chemical Engineering at Columbia University, and is on the Affiliated Faculty in NJIT’s Department of Chemistry and Environmental Science.
Webinar hosting presenter
President Digital, Robotics, & Enabling Technologies, Stryker
Mr. Cohen has worked in the medical device industry for over thirty-five years. He has focused on innovation that can improve patient outcomes and has managed R&D, manufacturing, regulatory, clinical research, quality, and marketing. Prior to his current position, Mr. Cohen served as the Vice President and Chief Technology Officer for the Joint Replacement division since rejoining Stryker in 2013 as part of the Mako acquisition. Mr. Cohen has over 25 patents and speaks globally at medical education conferences. He also serves on numerous boards and is the Chair of the Board of Trustees of NJIT. Mr. Cohen has been inducted as a Fellow to the American Institute for Medical and Biological Engineering and has a Bachelor of Science and a Master of Science in Mechanical Engineering and a Master of Science in Engineering Management, all from New Jersey Institute of Technology.
Webinar hosting presenter
Provost and Senior Executive Vice President
Fadi P. Deek is Provost and Senior Executive Vice President at New Jersey Institute of Technology (NJIT) where he began his academic career as a student in the early 1980s. He received his B.S. Computer Science, 1985; M.S. Computer Science, 1986; and Ph.D. Computer and Information Science, 1997, all from NJIT. In addition, Dr. Deek is Distinguished Professor with appointments in two departments: Informatics (in the College of Computing) and Mathematical Sciences (in the College of Science and Liberal Arts). He also serves as a member of the Graduate Faculty - Rutgers University Business School.

Over three and a half decades of professional affiliation with NJIT, Dr. Deek has progressed through faculty ranks and taught at all university levels, from first-year to advanced graduate courses; in different settings, from face-to-face to online; and to students with diverse abilities, from special needs to honors. During this time, he has been privileged to gain administrative experience in positions of increasing responsibility, from Coordinator and Director; to Assistant Chair, Associate Chair, Vice Chair, and Chair; and to Associate Dean, Dean, and now Provost and Senior Executive Vice President. In these positions, in addition to teaching and research, he has been actively involved in curricular development, program building, student recruitment, professional and regional accreditation, faculty/staff hiring and evaluation, promotion and tenure case-review, budget management, policy development, collective bargaining, and fundraising.

As a faculty member, Dr. Deek maintained an active funded-research program. His research interests included software engineering and open source software development, with applications to learning/collaborative/decision-support technologies, and computer science education. Dr. Deek has published over 150 articles in journals and conference proceedings, ten book chapters, and three books: Open Source – Technology and Policy, (Cambridge University Press, 2007, 369 pages co-authored with J. McHugh), Strategic Software Engineering – An Interdisciplinary Approach (Taylor & Francis Group - Auerbach Publications, 2005, 350 pages co-authored with J. McHugh and O. Eljabiri), Computer-Supported Collaboration with Applications to Software Development (Kluwer Academic Publishers, 2003, 265 pages co-authored with J. McHugh). Dr. Deek has also given over 40 invited and professional presentations and has been a Principal Investigator on a number of large projects, most notably the Computation and Communication: Promoting Research Integration in Science and Mathematics (C2PRISM), $3 million from the National Science Foundation. In addition, Dr. Deek has served as advisor or co-advisor to 14 PhD students.

Dr. Deek has received numerous teaching, research and service awards: The NJIT Student Senate Faculty of the Year Award, given to him in 1992 and 1993; the NJIT Honors Program Outstanding Teacher Award in 1992; the NJIT Excellence in Teaching Award in 1990 and 1999; the NJIT Master Teacher Designation in 2001 and the NJIT Robert W. Van Houten Award for Teaching Excellence in 2002. He has also been awarded the NJIT Overseers Public and Institute Service Award in 1997, the IBM Faculty Award in 2002, the NJIT Student Senate Administrator of the Year Award in 2007, and the NJIT Alumni Association Alumni Achievement Award in 2009. Dr. Deek has also been recognized in 2018 with an award from the World Lebanese Cultural Union (WLCU) in acknowledgment of his exceptional accomplishments and outstanding service to the community.
Webinar hosting presenter
Chief Operating Officer, Boston Pharmaceuticals
Joanne Beck joined Boston Pharmaceuticals in 2019 from Celgene, where she was Executive Vice President of Global Pharmaceutical Development and Operations, and oversaw Product Development, Global Manufacturing Operations, Supply Chain, Engineering and Quality. Prior to Celgene, she was SVP of Pharmaceutical Development at Shire. Prior to Shire she held roles of increasing responsibility in Process Development at Genentech and Amgen and in Operations at Abbott’s Pharmaceutical and Vascular Divisions. Beck holds a BA in Chemistry from Lewis and Clark College, a Ph.D. in Biochemistry and Molecular Biology from University of Oregon Medical School, and completed a postdoctoral fellowship in the department of Pharmaceutical Chemistry at the University of California, San Francisco. Dr. Beck serves on the board of directors for Orchard Therapeutics and Catabasis Pharmaceuticals.
Webinar hosting presenter
Chancellor for Rutgers University
Christopher J. Molloy was officially appointed the chancellor for Rutgers University–New Brunswick in February 2019. He had served as interim chancellor since July 2018. Molloy received his bachelor's degree in pharmacy from Rutgers and his doctoral degree from the joint Rutgers Graduate School of Biomedical Sciences at Robert Wood Johnson Medical School/Graduate School–New Brunswick. He was a postdoctoral fellow at the National Cancer Institute.

Dr. Molloy joined Rutgers University in 2007 as dean of the Ernest Mario School of Pharmacy. In 2011, he was appointed interim provost for biomedical and health sciences and successfully managed the complex integration of Rutgers and most of the former University of Medicine and Dentistry of New Jersey in 2013. Molloy also served as interim chancellor of Rutgers Biomedical and Health Sciences and then senior vice president for the Office of Research and Economic Development until his appointment as interim chancellor.

At Rutgers, he holds a faculty position as Distinguished Professor of Pharmacology and Toxicology and is a member of the Rutgers Cancer Institute of New Jersey, the American Association for Cancer Research, the American Society for Biochemistry and Molecular Biology, and the American Pharmacists Association. He was elected as a Fellow of the American Association for the Advancement of Science in 2016.

Prior to joining Rutgers, Molloy held senior research and management positions at Johnson & Johnson, 3-Dimensional Pharmaceuticals Inc., and Bristol Myers Squibb Pharmaceutical Research Institute. He is also a licensed pharmacist in New Jersey.
Hosted By
New Jersey Innovation Institute webinar platform hosts Proven Innovation Models in Life Sciences Through Industry-University Collaboration
The New Jersey Innovation Institute turns ideas into workable solutions.